Statistics for Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma: Early safety report of Turkish pass study
Total visits
views | |
---|---|
Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma: Early safety report of Turkish pass study | 1 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 1 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |